This is a routine scientific conference presentation with no material new data. Traders should await actual IND filing or clinical data readouts for catalysts. The stock's historical underperformance on neutral events suggests limited near-term upside.
Price Chart
Executive Summary
Century Therapeutics announced an oral presentation at the ADA 86th Scientific Sessions (June 5-8, 2026) highlighting preclinical data for CNTY-813, its iPSC-derived islet cell replacement therapy for type 1 diabetes. The presentation is a routine scientific milestone with no new clinical data or regulatory catalyst disclosed, and the stock has historically underperformed following similar neutral events.
Key Facts
- Oral presentation at ADA 2026 (June 5-8, New Orleans) on CNTY-813, an iPSC-derived islet cell replacement therapy for type 1 diabetes.
- CNTY-813 engineered with Allo-Evasion 5.0 to reduce need for chronic immunosuppression.
- Program is in IND-enabling development; no clinical data or regulatory submission announced.
Financial Impact
No financial figures disclosed; preclinical milestone with no revenue or cost impact.
Risk Factors
- No clinical data or regulatory milestone announced; presentation may not move stock.
- Program is early-stage (IND-enabling); high risk of failure in development.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3285451 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 25d ago | 8-K | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.41 (−7.84%) |
Oct 2, 2026 25d ago | Press Release | $1.53 $1.48 | ▼ −3.27% | ▼ −3.94% | $1.41 (−7.84%) |
Sep 22, 2026 4w ago | Institutional Cluster | $1.89 $1.76 | ▼ −6.88% | ▼ −6.16% | $1.41 (−25.40%) |
Sep 10, 2026 6w ago | 3 | $1.94 $2.00 | ▲ +3.09% | ▲ +3.54% | $1.41 (−27.32%) |
Aug 12, 2026 10w ago | 8-K | $1.96 $1.93 | ▼ −1.53% | ▼ −2.23% | $1.41 (−28.06%) |
Aug 12, 2026 10w ago | Press Release | $1.96 $1.93 | ▲ +1.53% | ▲ +2.23% | $1.41 (+28.06%) |
Jun 16, 2026 18w ago | 8-K | $2.25 $2.29 | ▲ +1.78% | ▲ +1.00% | $1.41 (−37.33%) |
Jun 15, 2026 19w ago | Insider Cluster | $2.18 $2.25 | ▲ +3.21% | ▲ +4.46% | $1.41 (−35.32%) |
Jun 9, 2026 19w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.41 (−33.49%) |
Jun 9, 2026 19w ago | Insider Cluster | $2.12 $2.24 | ▲ +5.66% | ▲ +3.96% | $1.41 (−33.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers